Givinostat
- Generic Name
- Givinostat
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C24H27N3O4
- CAS Number
- 497833-27-9
- Unique Ingredient Identifier
- 5P60F84FBH
- Background
Givinostat has been used in trials studying the treatment of Polycythemia Vera, Juvenile Idiopathic Arthritis, Duchenne Muscular Dystrophy (DMD), Chronic Myeloproliferative Neoplasms, and Polyarticular Course Juvenile Idiopathic Arthritis.
- Associated Conditions
- -
- Associated Therapies
- -
Open-Label Extension of the Dose Finding Study (DSC/08/2357/36) in Patients With Poly Juvenile Idiopathic Arthritis
- First Posted Date
- 2012-03-19
- Last Posted Date
- 2021-04-06
- Lead Sponsor
- Italfarmaco
- Target Recruit Count
- 1
- Registration Number
- NCT01557452
- Locations
- 🇨🇿
1st Faculty of Medicine and General Faculty Hospital, Praha, Czechia
Efficacy and Safety Dose Finding Study of Givinostat to Treat Polyarticular Course Juvenile Idiopathic Arthritis
Phase 2
Terminated
- Conditions
- Interventions
- First Posted Date
- 2010-12-16
- Last Posted Date
- 2014-04-16
- Lead Sponsor
- Italfarmaco
- Target Recruit Count
- 16
- Registration Number
- NCT01261624
- Locations
- 🇮🇹
Ospedale Meyer, Firenze, FI, Italy
🇮🇹Azienda Ospedaliera-Università di Padova, Padova, PD, Italy
🇷🇸Mother and Child Health Institute "Dr Vukan Cupic", Novi Beograd, Belgrade, Serbia
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath